Morgan Stanley’s LumiraDx Limited Common Shares LMDX Stock Holding History

Morgan Stanley’s Portfolio LMDX Stock Details LMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,637,552	Closed	-$103K	–	8122
2023 Q4	$103K	Buy	1,637,552 +593,776	+57%	+$68.8K	﹤0.01%	6153
2023 Q3	$245K	Hold	1,043,776	–	–	﹤0.01%	5496
2023 Q2	$501K	Sell	1,043,776 -318,425	-23%	-$166K	﹤0.01%	5209
2023 Q1	$633K	Buy	1,362,201 +192,944	+17%	+$185K	﹤0.01%	5122
2022 Q4	$1.05M	Sell	1,169,257 -42,894	-4%	-$45.2K	﹤0.01%	4843
2022 Q3	$1.24M	Buy	1,212,151 +530,495	+78%	+$880K	﹤0.01%	4758
2022 Q2	$1.81M	Buy	681,656 +462,444	+211%	+$1.85M	﹤0.01%	4610
2022 Q1	$1.32M	Buy	219,212 +40,256	+22%	+$326K	﹤0.01%	4806
2021 Q4	$1.59M	Buy	178,956 +169,901	+1,876%	+$1.51M	﹤0.01%	4742
2021 Q3	$75K	Buy	+9,055	New	+$73.4K	﹤0.01%	6523

Other funds holding LMDX

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Morgan Stanley's LMDX Position: Q1 2024 in Review

Morgan Stanley sold out of LumiraDx Limited Common Shares (LMDX) in Q1 2024, closing a stake of 1,637,552 shares — an estimated $103K sold.

Morgan Stanley first reported a position in LMDX in Q3 2021 and held it in 10 quarters. The position peaked at $1.81M in Q2 2022. 4 funds tracked by Wall St. Rank hold LMDX as of Q1 2024.

Morgan Stanley reported no remaining LumiraDx Limited Common Shares position as of Q1 2024 after selling out during the quarter.
Morgan Stanley sold 1,637,552 LumiraDx Limited Common Shares shares in Q1 2024, an estimated $103K.
Morgan Stanley first reported a position in LumiraDx Limited Common Shares in Q3 2021 and held it in 10 quarters.
Morgan Stanley's LumiraDx Limited Common Shares position peaked at $1.81M in Q2 2022.
4 funds tracked by Wall St. Rank held LumiraDx Limited Common Shares as of Q1 2024.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.